Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Sarah I. Jawed, Patricia L. Myskowski, Sarah McCue Horwitz, et al.
Journal of the American Academy of Dermatology (2014) Vol. 70, Iss. 2, pp. 223.e1-223.e17
Closed Access | Times Cited: 326

Showing 26-50 of 326 citing articles:

Cyclophosphamide in dermatology
Janet Kim, Jonathan Chan
Australasian Journal of Dermatology (2016) Vol. 58, Iss. 1, pp. 5-17
Closed Access | Times Cited: 53
MiRNAs in primary cutaneous lymphomas
Xin Yu, Zheng Li, Jie Liu
Cell Proliferation (2015) Vol. 48, Iss. 3, pp. 271-277
Open Access | Times Cited: 51
Resimmune, an anti-CD3 recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma
Arthur E. Frankel, Jung hui Woo, Chul Ahn, et al.
Haematologica (2015) Vol. 100, Iss. 6, pp. 794-800
Open Access | Times Cited: 51
Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks
Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3594-3594
Open Access | Times Cited: 44
What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?
Julien Catherine, Florence Roufosse
Seminars in Immunopathology (2021) Vol. 43, Iss. 3, pp. 439-458
Open Access | Times Cited: 39
Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell Lymphoma
Xiaofei Song, Shiun Chang, Lucia Seminario‐Vidal, et al.
Cancer Discovery (2022) Vol. 12, Iss. 5, pp. 1294-1313
Open Access | Times Cited: 26
Brentuximab as a Treatment for CD30+Mycosis Fungoides and Sézary Syndrome
Tarun Mehra, Kristian Ikenberg, Rudolf M. Moos, et al.
JAMA Dermatology (2014) Vol. 151, Iss. 1, pp. 73-73
Closed Access | Times Cited: 50
Identification of geographic clustering and regions spared by cutaneous T‐cell lymphoma in Texas using 2 distinct cancer registries
Ivan V. Litvinov, Michael T. Tetzlaff, Elham Rahme, et al.
Cancer (2015) Vol. 121, Iss. 12, pp. 1993-2003
Open Access | Times Cited: 48
Long-Term Complete Responses to Combination Therapies and Allogeneic Stem Cell Transplants in Patients With Sézary Syndrome
M. Polansky, Rakhshandra Talpur, Seema Daulat, et al.
Clinical Lymphoma Myeloma & Leukemia (2014) Vol. 15, Iss. 5, pp. e83-e93
Closed Access | Times Cited: 45
Usefulness of KIR3DL2 to Diagnose, Follow-Up, and Manage the Treatment of Patients with Sézary Syndrome
Charlotte Hurabielle, Nicolas Thonnart, C. Ram‐Wolff, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 14, pp. 3619-3627
Open Access | Times Cited: 45
Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome vs. HTLV-1+ leukemic cell lines
Elena Netchiporouk, Jennifer Gantchev, Matthew Tsang, et al.
Oncotarget (2017) Vol. 8, Iss. 56, pp. 95981-95998
Open Access | Times Cited: 45
Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study
Aaron R. Mangold, Agnieszka K. Thompson, Mark D. P. Davis, et al.
Journal of the American Academy of Dermatology (2017) Vol. 77, Iss. 4, pp. 719-727
Closed Access | Times Cited: 41
Clinical and epidemiological profile of patients with early stage mycosis fungoides
Gustavo Moreira Amorim, João Paulo Niemeyer‐Corbellini, Danielle Carvalho Quintella, et al.
Anais Brasileiros de Dermatologia (2018) Vol. 93, Iss. 4, pp. 546-552
Open Access | Times Cited: 40
The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T‐cell lymphoma
Julia Scarisbrick, M. Bagot, Pablo L. Ortiz‐Romero
British Journal of Haematology (2020) Vol. 192, Iss. 4, pp. 683-696
Open Access | Times Cited: 33
Paediatric cutaneous lymphomas including rare subtypes: A 40‐year experience at a tertiary referral centre
Silvia Alberti Violetti, Gianluca Avallone, Cristiana Colonna, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access | Times Cited: 4
Cyclophosphamide: An Overview
Aditya Kumar Bubna
Clinical Dermatology Review (2025) Vol. 9, Iss. 1, pp. 1-8
Open Access
HDAC10 and its implications in Sézary syndrome pathogenesis
Monika Pieniawska, Karolina Rassek, Bogumiła Skwara, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab
Francine M. Foss, Youn H. Kim, Julia Scarisbrick, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
The role of non-malignant B cells in malignant hematologic diseases
Daquan Gao
Hematology (2025) Vol. 30, Iss. 1
Open Access
Mycosis Fungoides and Sézary Syndrome
Robert Gniadecki, Minakshi Taparia, Jean Deschênes, et al.
(2025), pp. 49-82
Closed Access
Overexpression of FOXM1 drives mycosis fungoides progression by regulating the cell cycle
Kecen Liu, Huizhong Wang, Jingyang Dang, et al.
Journal of Dermatological Science (2025)
Closed Access
Granulomatous Disorders
D Geraint James, Alimuddin Zumla
CRC Press eBooks (2015), pp. 225-252
Closed Access | Times Cited: 36
Eosinophilia in Dermatologic Disorders
Elisabeth de Graauw, Helmut Beltraminelli, Hans‐Uwe Simon, et al.
Immunology and Allergy Clinics of North America (2015) Vol. 35, Iss. 3, pp. 545-560
Closed Access | Times Cited: 35
Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents
Sumana Devata, Ryan A. Wilcox
American Journal of Clinical Dermatology (2016) Vol. 17, Iss. 3, pp. 225-237
Closed Access | Times Cited: 34
Two distinct variants of mycosis fungoides (MF): Folliculotropic MF and erythrodermic MF
Hiroaki Kamijo, Makoto Sugaya
The Journal of Dermatology (2019) Vol. 46, Iss. 12, pp. 1136-1140
Closed Access | Times Cited: 33

Scroll to top